Search

Search Constraints

You searched for: Author/Creator Penchala, Sujan Dilly

Search Results

2. Cerebral function parameters in people with HIV switching integrase inhibitors: a randomized controlled trial. Issue 6 (15th December 2021)

3. Evidence of HIV pre-exposure or post-exposure prophylaxis (PrEP/PEP) among blood donors: a pilot study, England June 2018 to July 2019. (29th March 2021)

4. Pharmacokinetic/pharmacodynamic investigation of raltegravir with or without lamivudine in the context of HIV-1 pre-exposure prophylaxis (PrEP). (14th May 2021)

6. Pharmacokinetics of ß-d-N4-Hydroxycytidine, the Parent Nucleoside of Prodrug Molnupiravir, in Nonplasma Compartments of Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection. (10th March 2022)

7. Quantification of rilpivirine in human plasma, cervicovaginal fluid, rectal fluid and genital/rectal mucosal tissues using liquid chromatography–tandem mass spectrometry. (July 2014)

8. Total and Unbound Bictegravir Concentrations and Viral Suppression in Cerebrospinal Fluid of Human Immunodeficiency Virus-Infected Patients (Spanish HIV/AIDS Research Network, PreEC/RIS 56). (30th November 2019)

9. Total and Unbound Doravirine Concentrations and Viral Suppression in CSF. (21st September 2021)

10. Validation and clinical application of a novel LC–MS method for quantification of dolutegravir in breast milk. (19th November 2018)